References
- Shah MD, Bergeron AL, Dong JF, Lopez JA. Flow cytometric measurements of microparticles: Pitfalls and protocol modifications. Platelets 2008; 19(5)365–372
- Merten M, Pakala R, Thiagarajan P, Benedict CR. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIA-dependent mechanism. Circulation 1999; 99: 2577–2582
- Meziani F, Tesse A, David E, Martinez MC, Wangsteen R, Schneider F, Andriantohaina R. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol 2006; 169(4)1473–1483
- Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, Sturk A, Dignat-George F, Sabatier F, Camoin-Jau L, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842–1851
- Piccin A, Murphy WG, Smith OP. Circulating microparticle: Pathophysiology and clinical implications. Blood Rev 2007; 21: 157–171
- Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedghi A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649–2652
- Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95: 930–935
- Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alfa-granules. Blood 1999; 94: 3791–3799
- Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: A novel function of the p53 protein. Cancer Res 2006; 66: 4795–4801
- Sabapatha A, Gercel-Taylor C, Taylor DD. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reproduct Immunol 2006; 56: 345–355
- Shet AS. Characterizing blood microparticles: Technical aspects and challenges. Vascular Health Risk Management 2008; 4: 769–774